Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| First Tracks Biotherapeutics, Inc. | 42,000 | reported | 12 May 2026 | tx 14+174,350 |
| BridgeBio Oncology Therapeutics, Inc. | 30,000 | reported | 11 Aug 2025 | tx 2+30,000−30,000 |
| Xeris Biopharma Holdings, Inc. | 25,200 | reported | 12 Aug 2024 | tx 14+231,035 |
| Design Therapeutics, Inc. | 19,000 | reported | 10 Jun 2025 | tx 7+109,965 |
| ANAPTYSBIO, INC | 15,000 | reported | 20 Apr 2026 | tx 44+297,935−170,655 |
| Neos Therapeutics, Inc. | 0 | reported | 19 Mar 2021 | tx 11+126,215−138,715 |
| Trius Therapeutics Inc | 0 | reported | 11 Sept 2013 | tx 34+305,000−461,797 |
| Auspex Pharmaceuticals, Inc. | 0 | reported | 05 May 2015 | tx 6+45,000−248,470 |
| Poseida Therapeutics, Inc. | 0 | reported | 08 Jan 2025 | tx 18+207,983−256,097 |
| XERIS PHARMACEUTICALS INC | 0 | reported | 05 Oct 2021 | tx 8+42,456−73,335 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 12 May 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 42,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 15,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 15,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 6,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 6,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 6,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 6,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 11,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 11,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 11,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 11,000 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 9,200 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 9,200 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 10,600 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 16,510 | 0.00 USD | deriv |
| 20 Apr 2026 | OTHER | ANAPTYSBIO, INC | 5,500 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | ANAPTYSBIO, INC | 5,500 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,000 | 0.00 USD | deriv |
| 20 Apr 2026 | GRANT_AWARD | First Tracks Biotherapeutics, Inc. | 6,000 | 0.00 USD | deriv |